REVELATION BIOSCIENCES, INC. (REVB) Form 8-K Material Events
REVELATION BIOSCIENCES, INC. (REVB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: REVB
CIK: 1810560
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerThomas Kenaya
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-08-19 | 2026-08-17 | 8-K | 0001193125-26-357120 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | 4 | 0001193125-26-355663 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | 4 | 0001193125-26-355662 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | 4 | 0001193125-26-355661 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | 4 | 0001193125-26-355659 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | 4 | 0001193125-26-355658 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003611 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-338097 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-337967 | View SEC Doc Filr Page |
| 8-A12B | 2026-07-13 | — | 8-A12B | 0001193125-26-302077 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-10 | 8-K | 0001193125-26-302008 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-24 | 8-K | 0001193125-26-281200 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-06-01 | 8-K | 0001193125-26-251784 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001172661-26-002179 | View SEC Doc Filr Page |
| DEF 14A | 2026-05-11 | 2026-06-24 | DEF 14A | 0001193125-26-215804 | View SEC Doc Filr Page |
| ARS | 2026-05-11 | 2026-05-11 | ARS | 0001193125-26-215826 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001193125-26-212064 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001193125-26-211871 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-04-30 | 4 | 0001193125-26-201769 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-04-30 | 4 | 0001193125-26-201764 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-30 | 2026-06-24 | PRE 14A | 0001193125-26-196729 | View SEC Doc Filr Page |
| S-8 | 2026-04-15 | — | S-8 | 0001193125-26-157022 | View SEC Doc Filr Page |
| 8-K | 2026-03-19 | 2026-03-18 | 8-K | 0001193125-26-116012 | View SEC Doc Filr Page |
| 8-K | 2026-02-26 | 2025-11-06 | 8-K | 0001193125-26-076833 | View SEC Doc Filr Page |
| 10-K | 2026-02-26 | 2025-12-31 | 10-K | 0001193125-26-076552 | View SEC Doc Filr Page |